Chemotherapy of Rodent Malaria Drug Action Against Exo-Erythrocytic Stages and Drug Resistant Strains.

Abstract

Data were provided on the blood schizontocidal activity of one WRAIR compound and the causal prophylactic activity of 25 compounds, emphasis again being laid on a detailed evaluation of the latter. Most of the causal prophylactics tested have been in the 8-aminoquinoline series. A comparison of the rodent and simian models is presented below. Attention has been paid in particular to long-term studies designed to follow the inhibitory effect of drug mixtures on the emergence of drug resistance and its prevention. A sulphonamide was found to inhibit the development of resistance to WR 142,490 (mefloquine). Further studies were carried out on the modes of action of various compounds including mepacrine, chloroquine, quinine and new WRAIR compounds with quinine-type action. Minocycline and erythromycin have also been investigated further.

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 1975
Accession Number
ADA022498

Entities

People

  • Wallace Peters

Organizations

  • Liverpool School of Tropical Medicine

Tags

DTIC Thesaurus Topics

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Chemotherapy
  • Drug Resistance
  • Drug Therapy
  • Pharmacologic Actions
  • Resistance
  • Test And Evaluation

Fields of Study

  • Biology
  • Chemistry

Readers

  • Parasitology and Pharmacology of Malaria.
  • Theoretical Analysis.